仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Ficlatuzumab is a monoclonal antibody （McAb） targeting human hepatocyte growth factor （HGF）. Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion